Search
Now showing items 11-20 of 40
Effects Of Smoking On Hematological Parameters And Ferritin Levels
(2019)
Aim: Cigarette smoking is associated with an increased risk of cardiovascular diseases, including coronary artery disease, peripheral vascular disease, ischemic heart disease, atherosclerosis, myocardial infarction, and ...
Identification Of Clinical And Simple Laboratory Variables Predicting Responsible Gastrointestinal Lesions In Patients With Iron Deficiency Anemia
(2010)
Iron deficiency anemia (IDA) is a frequent disorder. Also, it may be a sign of underlying serious diseases. Iron deficiency points to an occult or frank bleeding lesion when occurred in men or postmenopausal women. In this ...
Expression Profiles Of The Individual Genes Corresponding To The Genes Generated By Cytotoxicity Experiments With Bortezomib In Multiple Myeloma
(2016)
Objective: Multiple myeloma (MM) is currently incurable due to refractory disease relapse even under novel anti-myeloma treatment. In silico studies are effective for key decision making during clinicopathological battles ...
Spinal Myeloid Sarcoma In Two Non-Leukemic Patients
(Japan Soc Internal Medicine, 2010)
Myeloid sarcoma, formerly termed granulocytic sarcoma or chloroma, consists of neoplastic granulocytic precursors and myeloblasts. Isolated chloromas (granulocytic sarcomas) are rare tumors. Spinal complications of chloromas, ...
Hypotension, Syncope, And Fever In Systemic Mastocytosis Without Skin Infiltration And Rapid Response To Corticosteroid And Cyclosporin: A Case Report
(2010)
Mast cell disorders are defined by an abnormal accumulation of tissue mast cells in one or more organ systems. In systemic mastocytosis, at least one extracutaneous organ is involved by definition. Although, systemic ...
Local Renin-Angiotensin System in Normal Hematopoietic and Multiple Myeloma-Related Progenitor Cells
(2014)
Objective: The prominent functions of the local renin-angiotensin system (RAS) in primitive hematopoiesis further support the hypothesis that local autocrine bone marrow RAS could also be active in neoplastic hematopoiesis. ...
Pharmacobiological Approach for the Clinical Development of Ruxolitinib in Myeloproliferative Neoplasms
(2015)
Ruxolitinib, a JAK1 and JAK2 inhibitor drug, has recently been approved for the treatment of patients with high- or intermediate-risk myelofibrosis with symptomatic splenomegaly. Ruxolitinib is the first clinically useful ...
Rebound Thrombocytosis Following Induction Chemotherapy Is An Independent Predictor of A Good Prognosis in Acute Myeloid Leukemia Patients Attaining First Complete Remission
(Karger, 2015)
There are very few data about the relationship between acute myeloid leukemia (AML) prognosis and bone marrow recovery kinetics following chemotherapy. In this study, we aimed to assess the prognostic importance and clinical ...